Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
The journal of antimicrobial chemotherapy - 69(2014), 3 vom: 12. Feb., Seite 651-650 |
| Beteiligte Personen: |
Munday, Jane C. [VerfasserIn] |
|---|
| BKL: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1937178552 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1937178552 | ||
| 003 | DE-627 | ||
| 005 | 20230518172638.0 | ||
| 007 | tu | ||
| 008 | 140214s2014 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw140213_1 |
| 035 | |a (DE-627)OLC1937178552 | ||
| 035 | |a (DE-599)GBVOLC1937178552 | ||
| 035 | |a (KEY)0114639420140200069000300651trypanosomabruceiaquaglyceroporin2isahighaffinityt | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 084 | |a 44.75 |2 bkl | ||
| 084 | |a 44.38 |2 bkl | ||
| 100 | 1 | |a Munday, Jane C. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Eze, Anthonius A. |4 oth | |
| 700 | 1 | |a Baker, Nicola |4 oth | |
| 700 | 1 | |a Glover, Lucy |4 oth | |
| 700 | 1 | |a Clucas, Caroline |4 oth | |
| 700 | 1 | |a Aguinaga Andrés, David |4 oth | |
| 700 | 1 | |a Natto, Manal J. |4 oth | |
| 700 | 1 | |a Teka, Ibrahim A. |4 oth | |
| 700 | 1 | |a McDonald, Jennifer |4 oth | |
| 700 | 1 | |a Lee, Rebecca S. |4 oth | |
| 700 | 1 | |a Graf, Fabrice E. |4 oth | |
| 700 | 1 | |a Ludin, Philipp |4 oth | |
| 700 | 1 | |a Burchmore, Richard J. S. |4 oth | |
| 700 | 1 | |a Turner, C. Michael R. |4 oth | |
| 700 | 1 | |a Tait, Andy |4 oth | |
| 700 | 1 | |a MacLeod, Annette |4 oth | |
| 700 | 1 | |a Mäser, Pascal |4 oth | |
| 700 | 1 | |a Barrett, Michael P. |4 oth | |
| 700 | 1 | |a Horn, David |4 oth | |
| 700 | 1 | |a De Koning, Harry P. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of antimicrobial chemotherapy |d Oxford : Oxford Univ. Press, 1975 |g 69(2014), 3 vom: 12. Feb., Seite 651-650 |w (DE-627)129426873 |w (DE-600)191709-2 |w (DE-576)01480087X |x 0305-7453 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2014 |g number:3 |g day:12 |g month:02 |g pages:651-650 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_252 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 936 | b | k | |a 44.75 |q AVZ |
| 936 | b | k | |a 44.38 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 69 |j 2014 |e 3 |b 12 |c 2 |h 651-650 | ||